Effectiveness of Telaprevir and Boceprevir Triple Therapy for Patients with Hepatitis C Virus Infection in a Large Integrated Care Setting
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effectiveness of Telaprevir and Boceprevir Triple Therapy for Patients with Hepatitis C Virus Infection in a Large Integrated Care Setting
Authors
Keywords
HCV, DAA, Antiviral therapy, Telaprevir, Boceprevir
Journal
DIGESTIVE DISEASES AND SCIENCES
Volume 59, Issue 12, Pages 3043-3052
Publisher
Springer Nature
Online
2014-08-07
DOI
10.1007/s10620-014-3294-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and efficacy of protease inhibitor based combination therapy in a single-center “real-life” cohort of 110 patients with chronic hepatitis C genotype 1 infection
- (2014) Malte H Wehmeyer et al. BMC GASTROENTEROLOGY
- Limited effectiveness and safety profile of protease inhibitor-based triple therapy against chronic hepatitis C in a real-world cohort with a high proportion of advanced liver disease
- (2014) Benjamin Maasoumy et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Comparative effectiveness of the hepatitis C virus protease inhibitors boceprevir and telaprevir in a large U.S. cohort
- (2013) L. I. Backus et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Similar Effectiveness of Boceprevir and Telaprevir Treatment Regimens for Hepatitis C Virus Infection on the Basis of a Nationwide Study of Veterans
- (2013) George N. Ioannou et al. Clinical Gastroenterology and Hepatology
- Simeprevir Increases Rate of Sustained Virologic Response Among Treatment-Experienced Patients With HCV Genotype-1 Infection: A Phase IIb Trial
- (2013) Stefan Zeuzem et al. GASTROENTEROLOGY
- 1413 SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR TREATMENT OF CHRONIC HCV GENOTYPE-1 INFECTION IN TREATMENT-NAÏVE PATIENTS: RESULTS FROM QUEST-2, A PHASE III TRIAL
- (2013) M. Manns et al. JOURNAL OF HEPATOLOGY
- Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890
- (2013) Christophe Hézode et al. JOURNAL OF HEPATOLOGY
- HCV F1/F2 patients: treat now or continue to wait
- (2013) Mitchell L. Shiffman et al. LIVER INTERNATIONAL
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eligibility and Safety of Triple Therapy for Hepatitis C: Lessons Learned from the First Experience in a Real World Setting
- (2013) Benjamin Maasoumy et al. PLoS One
- OPTN/SRTR 2011 Annual Data Report: Liver
- (2012) W. R. Kim et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Factors That Predict Response of Patients With Hepatitis C Virus Infection to Boceprevir
- (2012) Fred Poordad et al. GASTROENTEROLOGY
- A Dominant CD4+ T-Cell Response to Helicobacter pylori Reduces Risk for Gastric Disease in Humans
- (2012) Li Chen et al. GASTROENTEROLOGY
- Distribution of hepatitis C virus genotypes in a diverse US integrated health care population
- (2012) M. Michele Manos et al. JOURNAL OF MEDICAL VIROLOGY
- A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C
- (2012) I. M. Jacobson et al. JOURNAL OF VIRAL HEPATITIS
- Phase III results in Genotype 1 naïve patients: predictors of response with boceprevir and telaprevir combined with pegylated interferon and ribavirin
- (2011) Paul Y. Kwo LIVER INTERNATIONAL
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
- (2011) Kenneth E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients
- (2010) Ezequiel Ridruejo et al. HEPATOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started